17-β-oestradiol can also activate membrane-bound G-protein-coupled oestrogen receptors (GPER) which promotes triple-negative breast cancer (TNBC) and endometrial proliferation and cancer by activating cytoplasmic Src/EGFR/ERK signalling [69,70,91]. The gene discussed is GPER1; the disease is cancer.